Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience.

Lonze BE, Dagher NN, Liu M, Kucirka LM, Simpkins CE, Locke JE, Desai NM, Cameron AM, Montgomery RA, Segev DL, Singer AL.

Arch Surg. 2011 Nov;146(11):1261-6. doi: 10.1001/archsurg.2011.267.

PMID:
22106317
2.

Desensitization in HLA-incompatible kidney recipients and survival.

Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.

3.

Outcomes and discard of kidneys from pediatric donors after cardiac death.

Dagher NN, Lonze BE, Singer AL, Simpkins CE, Desai NM, Montgomery RA, Segev DL.

Transplantation. 2011 Apr 15;91(7):765-71. doi: 10.1097/TP.0b013e31820cfd27.

PMID:
21285917
4.

Transporting live donor kidneys for kidney paired donation: initial national results.

Segev DL, Veale JL, Berger JC, Hiller JM, Hanto RL, Leeser DB, Geffner SR, Shenoy S, Bry WI, Katznelson S, Melcher ML, Rees MA, Samara EN, Israni AK, Cooper M, Montgomery RJ, Malinzak L, Whiting J, Baran D, Tchervenkov JI, Roberts JP, Rogers J, Axelrod DA, Simpkins CE, Montgomery RA.

Am J Transplant. 2011 Feb;11(2):356-60. doi: 10.1111/j.1600-6143.2010.03386.x. Epub 2011 Jan 10.

5.

Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access.

Lonze BE, Dagher NN, Simpkins CE, Locke JE, Singer AL, Segev DL, Zachary AA, Montgomery RA.

Am J Transplant. 2010 Sep;10(9):2154-60. doi: 10.1111/j.1600-6143.2010.03191.x. Epub 2010 Jul 15.

6.

ABO incompatible renal transplantation: a paradigm ready for broad implementation.

Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, Cooper M, Simpkins CE, Singer AL, Stewart ZA, Melancon JK, Ratner L, Zachary AA, Haas M.

Transplantation. 2009 Apr 27;87(8):1246-55. doi: 10.1097/TP.0b013e31819f2024.

PMID:
19384174
7.

The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib.

Lonze BE, Dagher NN, Simpkins CE, Singer AL, Segev DL, Zachary AA, Montgomery RA.

Clin Transpl. 2009:377-84.

PMID:
20524301
8.

Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation.

Allen G, Simpkins CE, Segev D, Warren D, King K, Taube J, Locke J, Baldwin W, Haas M, Chivukula R, Montgomery RA.

Contrib Nephrol. 2009;162:35-46. doi: 10.1159/000170811. Epub 2008 Oct 31.

PMID:
19001812
9.

Prolonged waiting times for liver transplantation in obese patients.

Segev DL, Thompson RE, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, Maley WR.

Ann Surg. 2008 Nov;248(5):863-70. doi: 10.1097/SLA.0b013e31818a01ef.

PMID:
18948816
10.

C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA.

J Am Soc Nephrol. 2009 Jan;20(1):197-204. doi: 10.1681/ASN.2008030279. Epub 2008 Sep 5.

11.

Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.

Locke JE, Warren DS, Dominici F, Cameron AM, Leffell MS, McRann DA, Melancon JK, Segev DL, Simpkins CE, Singer AL, Zachary AA, Montgomery RA.

J Am Soc Nephrol. 2008 Oct;19(10):2011-9. doi: 10.1681/ASN.2008010078. Epub 2008 Jul 23.

12.

Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts.

Locke JE, Warren DS, Singer AL, Segev DL, Simpkins CE, Maley WR, Montgomery RA, Danovitch G, Cameron AM.

Transplantation. 2008 Apr 15;85(7):935-42. doi: 10.1097/TP.0b013e318168476d.

PMID:
18408571
13.

Effect modification in liver allografts with prolonged cold ischemic time.

Segev DL, Kucirka LM, Nguyen GC, Cameron AM, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, Maley WR.

Am J Transplant. 2008 Mar;8(3):658-66. doi: 10.1111/j.1600-6143.2007.02108.x.

14.

Obesity impacts access to kidney transplantation.

Segev DL, Simpkins CE, Thompson RE, Locke JE, Warren DS, Montgomery RA.

J Am Soc Nephrol. 2008 Feb;19(2):349-55. Epub 2007 Dec 19.

15.

Minimizing risk associated with elderly liver donors by matching to preferred recipients.

Segev DL, Maley WR, Simpkins CE, Locke JE, Nguyen GC, Montgomery RA, Thuluvath PJ.

Hepatology. 2007 Dec;46(6):1907-18.

PMID:
17918247
16.

Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis.

Segev DL, Nguyen GC, Locke JE, Simpkins CE, Montgomery RA, Maley WR, Thuluvath PJ.

Liver Transpl. 2007 Sep;13(9):1285-94.

17.

Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation.

Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA.

Am J Transplant. 2007 Jul;7(7):1797-807. Epub 2007 May 25.

18.

The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection.

Locke JE, Zachary AA, Haas M, Melancon JK, Warren DS, Simpkins CE, Segev DL, Montgomery RA.

Am J Transplant. 2007 Apr;7(4):842-6.

19.

Impact of bilateral versus single lung transplantation on survival in recipients 60 years of age and older: analysis of United Network for Organ Sharing database.

Nwakanma LU, Simpkins CE, Williams JA, Chang DC, Borja MC, Conte JV, Shah AS.

J Thorac Cardiovasc Surg. 2007 Feb;133(2):541-7. Epub 2007 Jan 10.

PMID:
17258596
20.

Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts.

Haas M, Montgomery RA, Segev DL, Rahman MH, Racusen LC, Bagnasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES.

Am J Transplant. 2007 Mar;7(3):576-85. Epub 2007 Jan 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk